Decision Diagnostics (DECN)
Decision Diagnostics Corp. is a healthcare technology company listed on OTC Markets as common stock. The company develops smartphone-based electronic medical record, or EMR, technologies and related e-health software for use at the point of care. Its business includes prescription and non-prescription diagnostics, home testing products for people with chronic illness, and direct-to-patient diabetes program fulfillment services. Decision Diagnostics also manufactures and distributes a range of glucose-testing products, including GenUltimate! glucose test strips for at-home use, PetSure! strips for veterinary testing, and the GenUltimate! 4Pets glucose system for dogs, cats, and horses. In addition, it offers software products such as MD@Hand, Practice Probe, and ResidenceWare, while also holding intellectual property and specialty manufacturing equipment. The company was founded in 2000 and is based in Westlake Village, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-DECN
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
0.38 K
|
—
|
—
|
—
|
—
|
—
|
—
|